Additionally, annual CD4 snapshots from a public sector cohort in Western Cape Province, South Africa, showed ART-experienced patients with AHD increased from 14.3% to 56.7% between 2008 and 2017 [44]. The gene discussed is CD4; the disease is mitochondrial DNA depletion syndrome 4a.